1. Home
  2. ARQQ vs LEXX Comparison

ARQQ vs LEXX Comparison

Compare ARQQ & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arqit Quantum Inc.

ARQQ

Arqit Quantum Inc.

HOLD

Current Price

$27.44

Market Cap

422.6M

Sector

Technology

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$0.67

Market Cap

16.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQQ
LEXX
Founded
2017
2004
Country
United Kingdom
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
422.6M
16.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARQQ
LEXX
Price
$27.44
$0.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$60.00
$1.50
AVG Volume (30 Days)
363.7K
1.5M
Earning Date
12-09-2025
01-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$530,000.00
$705,923.00
Revenue This Year
$1,054.72
$13.35
Revenue Next Year
$30.00
$78.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
52.05
52 Week Low
$11.00
$0.46
52 Week High
$62.00
$2.38

Technical Indicators

Market Signals
Indicator
ARQQ
LEXX
Relative Strength Index (RSI) 51.02 42.17
Support Level $21.43 $0.46
Resistance Level $29.20 $0.72
Average True Range (ATR) 1.84 0.09
MACD 0.67 0.01
Stochastic Oscillator 70.97 84.14

Price Performance

Historical Comparison
ARQQ
LEXX

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: